Every Form 4 that TRULIEVE CANNABIS CORP (TCNNF) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow TCNNF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TCNNF filings page.
Trulieve Cannabis Corp. Chairman and CEO Kim A. Rivers reported an open-market sale of 136,811 Subordinate Voting Shares at a weighted average price of $8.756 per share. After this sale, she directly holds 1,476,913 Subordinate Voting Shares.
The sale was effected under a Rule 10b5-1 plan to sell 2.5 million shares that she adopted on March 16, 2026. A first tranche of 1,699,007 Subordinate Voting Shares under this plan has been completed, and she has notified the administering broker-dealer of her intention to terminate the plan on August 11, 2026 before any additional sales.
Rivers also has exposure through Multiple Voting Shares that are convertible into Subordinate Voting Shares on a one-for-100 basis, including holdings reported directly and indirectly via Traunch IV LLC, for which she disclaims beneficial ownership except to the extent of her pecuniary interest.
Trulieve Cannabis Corp. Chairman and CEO Kim A. Rivers reported open-market sales of 1,080,000 Subordinate Voting Shares. She sold 380,000 shares at a weighted average price of $8.469 per share, 400,000 shares at $8.169 per share, and 300,000 shares also at $8.169 per share.
These sales were made under a Rule 10b5-1 plan adopted on March 16, 2026 to sell approximately 2.5 million shares, with a first tranche of 1,699,007 shares covered by a Form 144 filed on June 17, 2026. After these transactions, Rivers directly holds 1,613,724 Subordinate Voting Shares.
She also holds Multiple Voting Shares convertible into 15,166,700 Subordinate Voting Shares directly, and an additional 986,700 underlying Subordinate Voting Shares are held indirectly through Traunch IV LLC, where she may be deemed to exercise voting and investment control but disclaims beneficial ownership except for her pecuniary interest.
Trulieve Cannabis Corp. Chairman and CEO Kim A. Rivers reported open-market sales of 482,196 Subordinate Voting Shares. These sales occurred on June 17, 18 and 22, 2026 at weighted average prices around $9.35–$9.46 per share under transaction code S.
The filing notes these transactions were effected pursuant to a Rule 10b5-1 plan to sell 2.5 million shares adopted on March 16, 2026, with a Form 144 covering a first tranche of 1,699,007 Subordinate Voting Shares filed on June 17, 2026. Following the reported sales, Rivers directly holds 2,693,724 Subordinate Voting Shares.
She also has Multiple Voting Shares convertible into 15,166,700 Subordinate Voting Shares directly and 986,700 Subordinate Voting Shares indirectly through Traunch IV LLC, as disclosed in the derivative holdings and related footnotes.
Trulieve Cannabis Corp. Chairman and CEO Kim A. Rivers reported several equity-related transactions. On March 13, 2026, she received a grant of 155,561 stock options with an exercise price of $6.40 per share, expiring on March 13, 2033. She was also granted 218,750 restricted stock units (RSUs), each representing one subordinate voting share; 50% vest on December 1, 2027 and 50% on December 1, 2028.
On March 3, 2026, 8,200 Multiple Voting Shares were converted into 820,000 Subordinate Voting Shares on a one-for-100 basis. Following these transactions, she holds 3,175,920 subordinate voting shares directly. Footnotes state she also holds 151,667 Multiple Voting Shares directly, 9,867 Multiple Voting Shares through Traunch IV LLC (with beneficial ownership disclaimed except for her pecuniary interest), and stock options vested as of December 1, 2025 to acquire 1,152,960 subordinate voting shares.
Trulieve Cannabis Corp. President Jason Pernell received equity awards in the form of restricted stock units (RSUs) and stock options. On March 13, 2026, he was granted 41,668 stock options, each allowing him to buy one subordinate voting share at an exercise price of $6.40 per share, expiring on March 13, 2033. The option vests in three equal annual installments on December 1, 2026, December 1, 2027, and December 1, 2028.
On the same date, he also acquired 58,594 subordinate voting shares as a grant of RSUs, with no cash purchase price. Each RSU represents one subordinate voting share. Half of these RSUs will vest on December 1, 2027, and the remaining half on December 1, 2028. Following the RSU grant, his direct holdings of subordinate voting shares increased to 581,795 shares. Footnotes state that separate trusts associated with him also hold 22,635 and 22,636 Multiple Voting Shares, which are convertible into an aggregate of 4,527,100 subordinate voting shares.
Trulieve Cannabis Corp. reported an equity compensation grant to executive Christine Ann Hersey, Chief Corporate Affairs & Strategy. She received 41,668 stock options with an exercise price of $6.40 per share, expiring on March 13, 2033. These options vest in three equal annual installments on December 1, 2026, December 1, 2027, and December 1, 2028.
Hersey also received 58,594 restricted stock units (RSUs), each representing one subordinate voting share. Half of these RSUs vest on December 1, 2027, and the remaining half on December 1, 2028. Following the RSU grant, she directly holds 143,767 subordinate voting shares. These are compensation-related awards rather than open‑market purchases.
Trulieve Cannabis Corp. Chief Production Officer Kyle Landrum received new equity awards as compensation. He was granted options to buy 41,668 subordinate voting shares at an exercise price of $6.40 per share, expiring on March 13, 2033. These options vest in three equal annual installments on December 1, 2026, December 1, 2027, and December 1, 2028.
Landrum also received 58,594 restricted stock units, each representing one subordinate voting share. Half of these RSUs vest on December 1, 2027 and the remaining half on December 1, 2028. Following the RSU grant, he directly owns 258,776 subordinate voting shares.
Trulieve Cannabis Corp. Chief Financial Officer Jan Reese reported receiving new equity compensation awards. Reese was granted options to buy 41,668 subordinate voting shares at an exercise price of $6.4000 per share, expiring on March 13, 2033. These options vest in three equal annual installments on December 1, 2026, December 1, 2027, and December 1, 2028, and 41,668 options are shown as held after the grant. Reese also received 58,594 restricted stock units, each representing one subordinate voting share. According to the award terms, 50% of these RSUs vest on December 1, 2027 and the remaining 50% vest on December 1, 2028, with 58,594 shares reported as held following this grant. These are compensation-related acquisitions, not open‑market purchases or sales.
Trulieve Cannabis Corp. reported that Chief Legal Officer Eric Powers received equity-based compensation awards. He was granted stock options for 41,668 subordinate voting shares at an exercise price of $6.40 per share, expiring on March 13, 2033, vesting in three equal annual installments starting December 1, 2026.
Powers also received 58,594 restricted stock units, each representing one subordinate voting share. Half of these RSUs vest on December 1, 2027, and the remaining half on December 1, 2028. Following these awards, he directly owns 245,311 subordinate voting shares, and 1,000 additional shares are held indirectly by his spouse.
Trulieve Cannabis Corp. Chief Technology Officer Nilyum Jhala reported equity compensation awards. Jhala received 58,594 restricted stock units, each representing one subordinate voting share, with 50% vesting on December 1, 2027 and 50% on December 1, 2028.
Jhala was also granted a stock option for 41,668 subordinate voting shares at an exercise price of 6.40 per share, vesting in three equal annual installments on December 1, 2026, December 1, 2027, and December 1, 2028, and expiring on March 13, 2033. Following these awards, Jhala directly owns 239,254 subordinate voting shares and has indirect beneficial ownership of 7,000 shares held by a spouse.
Walsh Brett R. reported acquisition or exercise transactions in this Form 4 filing.
Trulieve Cannabis Corp. reported that Chief Accounting Officer Brett R. Walsh received an equity grant in the form of 28,711 restricted stock units, each representing one subordinate voting share. Half of these RSUs vest on December 1, 2027, and the other half on December 1, 2028. Following this compensation-related award, Walsh directly holds 140,305 subordinate voting shares.
Thronson Susan reported acquisition or exercise transactions in this Form 4 filing.
Trulieve Cannabis Corp. director Susan Thronson received an equity award in the form of restricted stock units (RSUs). The grant covers 23,438 RSUs, each representing a contingent right to receive one Trulieve subordinate voting share at no cash cost.
The RSUs vest on the earliest of the end of her board service, a change of control of Trulieve, or December 1, 2032. Following this award, Thronson holds 64,543 subordinate voting shares directly and 9,740 shares indirectly through the Thronson Family Trust UA.
MILLNER THOMAS L reported acquisition or exercise transactions in this Form 4 filing.
Trulieve Cannabis Corp. director Thomas L. Millner received an equity compensation award in the form of 23,438 subordinate voting share units on March 13, 2026. These units were granted at no cash cost to him and increase his direct holdings to 72,543 shares.
The award is structured as restricted stock units (RSUs), each representing a contingent right to receive one Trulieve subordinate voting share. The RSUs will vest upon the earliest of the end of Millner’s board service, a change of control at Trulieve, or December 1, 2032, tying his compensation to long-term company performance.
Trulieve Cannabis Corp. director Matthew J. Foulston reported an award of 23,438 subordinate voting shares in the form of restricted stock units. These RSUs were granted at no cash cost as equity compensation and increase his direct holdings to 34,767 shares after the transaction.
The footnote explains that each RSU converts into one subordinate voting share, vesting on the earliest of his service ending on the board, a change of control of Trulieve, or December 1, 2032. This is a routine compensation-related equity grant rather than an open-market purchase or sale.
Morreau Jane Cecil reported acquisition or exercise transactions in this Form 4 filing.
Trulieve Cannabis Corp. director Jane Cecil Morreau reported an award of 23,438 Subordinate Voting Shares on 2026-03-13, recorded at $0.00 per share, bringing her reported direct holdings to 65,778 shares.
According to the footnote, this represents a grant of restricted stock units (RSUs), each equal to one Trulieve subordinate voting share. The RSUs will vest on the earliest of the end of her board service, a change of control of Trulieve, or December 1, 2032.
Trulieve Cannabis Corp. director Richard S. May reported an equity compensation grant of 23,438 restricted stock units (RSUs) tied to the company’s subordinate voting shares. The award was recorded at no cash purchase price, reflecting a compensation-related, not open-market, acquisition.
Each RSU represents the right to receive one subordinate voting share. The RSUs will vest on the earliest of the end of May’s board service, a change of control of Trulieve, or December 1, 2032. Following this grant, May directly holds 593,534 subordinate voting shares.
Healy Peter reported acquisition or exercise transactions in this Form 4 filing.
Trulieve Cannabis Corp. director Peter Healy reported an equity compensation grant in the form of restricted stock units (RSUs) covering 23,438 subordinate voting shares. The award was recorded at a price of $0.00 per unit, reflecting a grant rather than a market purchase. Following this grant, Healy is shown as holding 72,673 subordinate voting shares. Each RSU represents a contingent right to receive one Trulieve subordinate voting share and will vest on the earliest of the end of Healy’s board service, a change of control of Trulieve, or December 1, 2032.
Beshears Thad reported acquisition or exercise transactions in this Form 4 filing.
Trulieve Cannabis Corp. director Beshears Thad received an award of 23,438 restricted stock units (RSUs) tied to Subordinate Voting Shares. The grant was reported at a price of zero, indicating a compensation-related award rather than an open‑market purchase.
Each RSU represents the right to receive one Trulieve subordinate voting share. The RSUs will vest on the earliest of the end of his board service, a change of control of Trulieve, or December 1, 2032. After this grant, he directly holds 2,487,043 Subordinate Voting Shares. He also directly holds 15,000 Multiple Voting Shares, which are convertible on a one‑for‑100 basis into an aggregate of 1,500,000 Subordinate Voting Shares.
Trulieve Cannabis Corp.'s Chief Sales Officer reported an automatic share withholding related to equity compensation. On December 1, 2025, 16,744 subordinate voting shares were disposed of at $5.39 per share under transaction code “F,” which indicates shares withheld to cover tax obligations on vesting restricted stock units. After this tax-related transaction, the officer directly beneficially owned 174,709 subordinate voting shares of Trulieve Cannabis Corp. This filing reflects routine administration of previously granted RSUs rather than an open‑market trade.
Trulieve Cannabis Corp. Chief Legal Officer reports tax-related share withholding
Trulieve Cannabis Corp. officer Eric Powers, the company’s Chief Legal Officer, reported a routine transaction involving the company’s subordinate voting shares. On December 1, 2025, 18,206 subordinate voting shares were withheld at a price of $5.39 per share to cover tax liabilities arising from the vesting of previously granted restricted stock units. This did not represent an open-market sale.
After this withholding, Powers beneficially owns 186,717 subordinate voting shares directly and an additional 1,000 subordinate voting shares indirectly through his spouse. The filing is made on Form 4 and reflects equity compensation and related tax settlement rather than a discretionary trade.
Trulieve Cannabis Corp. reported an insider equity transaction by its Chief Technology Officer. On December 1, 2025, 18,041 subordinate voting shares were withheld at a price of $5.39 per share to cover tax obligations arising from the vesting of previously granted restricted stock units. After this tax withholding, the reporting person beneficially owns 180,660 subordinate voting shares directly and an additional 7,000 shares indirectly through a spouse. This filing reflects a routine administrative adjustment related to equity compensation rather than an open-market trade.
Trulieve Cannabis Corp. reported an insider equity transaction by its Chief Production Officer on a Form 4. On December 1, 2025, 18,359 subordinate voting shares were withheld at a price of $5.39 per share to cover tax obligations arising from the vesting of previously granted restricted stock units. After this tax‑withholding event, the reporting person beneficially owned 200,182 subordinate voting shares directly. This filing reflects routine equity compensation and related tax settlement rather than an open-market purchase or sale.
Trulieve Cannabis Corp. Chairman and CEO Kim Rivers reported a routine insider transaction related to equity compensation. On December 1, 2025, 63,237 Subordinate Voting Shares were withheld at $5.39 per share to cover tax obligations arising from the vesting of previously granted restricted stock units. After this withholding, she beneficially owned 2,137,170 Subordinate Voting Shares directly.
The filing also notes additional holdings, including Multiple Voting Shares and vested stock options. As of this report, Rivers is listed as a Director, 10% owner, Chairman and CEO, and the filing is made by a single reporting person.
Trulieve Cannabis Corp. disclosed an insider equity transaction by its Chief Accounting Officer on a Form 4. On December 1, 2025, the officer had 7,850 subordinate voting shares withheld at a price of $5.39 per share. The filing explains that these shares were withheld to cover tax liabilities arising from the vesting of previously granted restricted stock units (RSUs), rather than being sold in an open-market trade. Following this administrative tax-withholding event, the officer reports beneficial ownership of 74,289 subordinate voting shares, held directly.
Trulieve Cannabis Corp.'s president filed a Form 4 reporting an automatic share withholding tied to equity compensation. On December 1, 2025, 7,009 Subordinate Voting Shares were withheld at $5.39 per share to cover taxes due upon the vesting of previously granted restricted stock units. After this tax withholding, the reporting person directly owns 523,201 Subordinate Voting Shares.
The filing also notes indirect holdings of 22,635 Multiple Voting Shares in one trust and 22,636 Multiple Voting Shares in another trust, over which the reporting person may be deemed to have voting and investment control. These Multiple Voting Shares are convertible into Subordinate Voting Shares on a one-for-100 basis, representing an aggregate of 4,527,100 Subordinate Voting Shares.
Trulieve Cannabis Corp. (TCNNF): Director equity grants reported. On 11/04/2025, a director reported receiving 11,329 subordinate voting shares via a grant of restricted stock units at a stated price of $0. Following the grant, beneficial ownership of subordinate voting shares was 11,329, held directly.
The filing also reports an award of stock options for 18,859 subordinate voting shares with an exercise price of $6.62; the options are fully vested. The RSUs vest on the earliest of the end of board service, a change of control, or December 1, 2031.